| Compliance CPSIA 2026 |  |
| Resirene - SVHC Statement 2026 | |
| Resirene Allergens 2026 | |
| Resirene BPA Free Letter 2026 | |
| Resirene CONEG 2026 | |
| Resirene Materials of Animal Origin 2026 | |
| Resirene Ozone Depleting Substances 2026 | |
| Resirene Absence of Latex 2026 | |
| Resirene Prop 65 Compliance 2026 | |
| Absence of Oxo Additives 2026 | |
| Absence of Deutarated bis 2026 | |
| RESIRENE REACH Registration Notification 2026 | |
| Resirene EU Regulations Compliance Letter 2026 | |
| Absence of PBT Bioaccumulative 2026 | |
| Shelf life 2026 | |
PFAS Absence 2026
| |
| Resirene EU 71 Compliance Letter 2022 | |
Resirene USP Compliance Letter 2026
| |
Absence of Phtalates 2026
| |
| ISO 9001:2015 RESIRENE 2019-2025 | |
| Resirene FDA Compliance Letter 2026 | |
| Resirene RoHS 2026 | |
| Compliance Statement QrPS25 | |
| Certificate for Awarding and Use of the "OK biobased" Conformity Mark | |
| UL | |
| Canadian Environmental Protection Act | |
| EU Cosmetic Reg 2026 | |
| Non use of Conflict Minerals 2026 | |
| Non Russian Raw Materials 2024 | |
| Heavy Metals Content 2026 | |
| MOAH MOSH Compliance 2019 | |
